Calls for Proposals

 

APPLICATION PROCEDURE: 
BEFORE to complete the online form, read very CAREFULLY the explanatory note (français - english). 
 
 
 
- EMERGENCE 2025 - NEW TEAM 
  
                                                 Deadline: March 31, 2025, for electronic submission

The "Emergence – New team" call for research proposals is intended to support, over a period of 3 years a young researcher (CR/DR Inserm or Cnrs or other French Institution), teacher in a French university (MCU/PU), clinician-scientist (MCU-PH/PU-PH), French or not, wishing to set up in France a new independent or autonomous group to develop an original clinical or fundamental research project on MS or associated disorders.

The call is open to scientists of any nationality who may reside in any country in the world at the time of application, but the project must be developed within a French research structure. The applicant must hold a permanent position in France (Inserm, Cnrs, university, Cea, Inra…).

The allocated budget will be 150 k € per year for 3 years.
 
- Regulations (please download - PDF)

Before your online submission, fill in the application form, depends on your demand, for:

 

 
- ANNUAL CALL
                                                    Deadline: March 31 2024, for electronic submission
 
For investigator-initiated support requests, no topic restrictions are imposed, other than the required demonstration of relevance to Multiple Sclerosis.
 
- Regulations (please download) 

Before your online submission, fill in the application form, depends on your demand, for:

  

  

- SCIENCES HUMAINES, SOCIALES, ECONOMIQUES 
                                                Deadline: March 31, 2024, for electronic submission
 
Approche personnalisée, éthique, sociologique et économique de la SEP par la recherche. Cet AAP vise à soutenir des recherches pluridisciplinaires innovantes sur des méthodes d’approches personnalisées de la SEP à tous les stades de la maladie, sur son impact social et économique, sur le traitement et l’utilisation des données cliniques associées.
 
- Procédures et recommandations (à télécharger SVP) 

Before your online submission, fill in the application form:

 

 

- WORKING VISITS:

                                                      Deadline: No deadline - throughout the year
 
To facilitate exchanges between clinical centres and/or laboratories involved in MS. Travel may be within, to, or from France.

- Regulations (please download)

Before your online submission, fill in the application form:

 

 

 

COMMUNICATION PROPOSALS 

 

- ORGANISER UNE CONFERENCE SUR LA SCLEROSE EN PLAQUES

Afin de développer ses actions d’information à destination des chercheurs et cliniciens, la Fondation peut soutenir financièrement des manifestations scientifiques. 

 - Procédures (à télécharger, merci)

Soumission des demandes

Toute demande de soutien d’un événement scientifique doit être adressée à la Fondation par email à scientific@francesep.org  

 

 

REMINDER OF THE COMMITMENT OF THE RESEARCHERS TO THE FOUNDATION FRANCE SCLEROSE EN PLAQUES

The foundation France Sclérose en Plaques, supports your research through private donations from individuals, sponsors and companies. Fundraising is difficult. Therefore, the Foundation believes that it is absolutely necessary to inform our donors that their generosity has contributed significantly to the achievement of important results in multiple sclerosis research. The foundation financially supports your research because it believes in your quality as a researcher and in your scientific research potential. France Sclérose en Plaques’ objective is to continue this mission to support a growing number of research projects.

However, the increasing support of the Foundation cannot be made without the growth of France Sclérose en Plaques’ fame. For this reason, the foundation’s actions must be visible to the scientific community, the media and donors. We count on you to communicate and to cite the foundation when associated with your advances in multiple sclerosis research. As stated in the agreements established between the foundation and your research institutes , as well as in the letters of acceptance that you have signed, we remind you that you have made a commitment to quote the name of France Sclérose en Plaques Foundation, “France Sclérose en Plaques”, in all publications, oral communications and posters benefiting from France Sclérose en Plaques’ financial support. The lack of visibility of support by the foundation in your research is very damaging to our efforts to fundraise and thus continue to support your research.


Brigitte Taittinger-Jouyet (Chairman of France Sclérose en Plaques), Jean Pelletier, Laure Michel and Pierre-Olivier Couraud (President and Vice-presidents of the scientific committee of France Sclérose en Plaques).

 

 

 

 

 

 

Dernière mise à jour : 22/10/2024
Appelée SEP ou multiple sclerosis en anglais, la sclérose en plaques est une maladie neurologique qui détruit la gaine de myéline. Qu’elle soit de forme rémittente (à poussées) ou de forme progressive, il n’existe à ce jour aucun traitement curatif de cette affection. La Fondation œuvre depuis 1969 avec ses bénévoles, aux côtés des facultés, de l’INSERM, du CNRS et de différents instituts de recherche médicale, dont l’ICM et Pasteur.